Antares Pharma, Inc. (NASDAQ:ATRS)

CAPS Rating: 3 out of 5

The Company develops, produces and markets pharmaceutical delivery products, including transdermal gels, oral fast melting tablets and reusable needle-free and disposable mini-needle injector systems.

Recs

1
Player Avatar bruceedge (< 20) Submitted: 6/19/2011 2:17:24 PM : Outperform Start Price: $1.97 ATRS Score: +77.23

interesting product line addressing some large markets and very
strong technical chart with insider buying

Report this Post 1 Reply

Featured Broker Partners


Advertisement